News4 days ago
Stealth BioTherapeutics Announces Positive End-of-Phase 2 Meeting with FDA on the Development of Elamipretide in Patients with Dry Age-related Macular Degeneration
Elamipretide showed favorable effect on photoreceptor integrity (ellipsoid zone attenuation) and visual function (low light – best corrected visual acuity) Positive end-of-phase 2 FDA meeting confirmed...
